- For high-risk patients, statins are indisputably beneficial; supplements appeal to lower-risk people or those with drug side effects.
- The best cholesterol supplements are concentrated mushroom polysaccharides - the first statins themselves came from mushrooms.
- Quality criteria: water-based extraction, a multi-pathway formula, and a standardised sufficient dose.
- A formula combining several complementary pathways outperforms single ingredients - the principle behind AURI 25.
Why do we even look for the best cholesterol supplements?
Clearly, for people at high risk of heart disease the benefit of cholesterol drugs is indisputable (so do not take chances if your condition is serious). But increasingly, people with lower stroke risk — or those who have experienced drug side effects — have started looking toward cholesterol supplements. So which cholesterol supplements are best?
The best cholesterol supplements come from mushrooms
In Asia, medicinal mushrooms have been used for centuries, while in the West mushroom research has only been "catching up" in recent decades. Research scientifically supports their traditional use. Medicinal mushrooms repeatedly provide answers to problems that afflict humanity: antimalarials,4 antifungals,5 immunosuppressants (for arthritis, organ transplantation),6 and DPP-4 inhibitors (for diabetes).7 In some highly developed countries, such as Japan, medicinal mushrooms have been an approved standard cancer treatment for more than 30 years. Importantly, the first-generation statins were themselves extracted from mushrooms.
Best supplements for lowering cholesterol without side effects
Not all supplements are equal. The difference between cheap mushroom powder and a concentrated polysaccharide extract is like the difference between herbal tea and a pharmaceutical preparation. What to look for:
- Extraction method — only water-based extraction yields the active polysaccharides; alcohol extracts do not.
- Multi-mushroom / multi-pathway formula — different mushrooms and compounds act through complementary cholesterol pathways. A single ingredient cannot do this.
- Standardised, sufficient dose — concentration matters; cheap, weak products give weak results.
A formula combining several complementary pathways is more effective than single ingredients — which is precisely the principle behind a purpose-built cholesterol formula.
The best cholesterol supplements are concentrated, water-based, multi-pathway mushroom formulas - not simple powders. The first statins came from mushrooms.
AURI 25 by Zenius Labs™ →The most effective are concentrated mushroom-polysaccharide extracts. Research shows they can lower cholesterol with effectiveness similar to statins, without side effects. It is important to choose not simple mushroom powders but a specially designed multi-extract formula such as AURI 25 by Zenius Labs™.
Mushroom powder is simply ground mushrooms with a very low concentration of active compounds. A polysaccharide extract concentrates the active substances — and only water-based extraction yields them, since alcohol extraction does not. The difference is like herbal tea versus a pharmaceutical preparation.
Generally well tolerated, but because they are studied as acting similarly to statins, always inform your doctor about any supplement you take, especially if you are on cholesterol or other medication.
Different mushrooms and compounds act through complementary cholesterol pathways. A formula combining several — such as AURI 25, which pairs Auricularia and Pleurotus extracts with policosanol and monacolin K — addresses cholesterol from multiple angles, more effectively than any single ingredient.
- Research reference — en.wikipedia.org. En
- Research reference — en.wikipedia.org. En
- Research reference — en.wikipedia.org. En
- Research reference — en.wikipedia.org. En
- Research reference — cancer.gov. Cancer
- PubMed 11956737. PubMed
- PMC5810204. PMC
- Research reference — hindawi.com. Hindawi
- Mushroom polysaccharides and lipid metabolism. ScienceDirect
- PMC3834517. PMC
- PubMed 22939338. PubMed
- Mushroom polysaccharides and lipid metabolism. ScienceDirect
- PubMed 9836425. PubMed
- Research reference — dl.begellhouse.com. Dl
- Research reference — thrombosisresearch.com. Thrombosisresearch
- PubMed 19241585. PubMed
- Chen JT et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005. PubMed
- Yoon SJ et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thrombosis research. 2003. PubMed
- Bian C et al. A Novel Polysaccharide from AuriculariaAuricula Alleviates Thrombosis Induced by Carrageenan in Mice. Molecules (Basel, Switzerland). 2022. PubMed
- Shi Q et al. Isolation, Characterization, and Antioxidant Activity of Melanin from Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2023. PubMed
- Yin CM et al. Physicochemical Properties and Antioxidant Activity of Natural Melanin Extracted from the Wild Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2022. PubMed
- González-Bonilla A et al. Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico. International journal of medicinal mushrooms. 2022. PubMed
- Abrams DI et al. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC complementary and alternative medicine. 2011. PubMed
- Belobrajdic DP et al. β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & function. 2024. PubMed
- Sato M et al. Long-term intake of Tamogi-take mushroom (Pleurotus cornucopiae) mitigates age-related cardiovascular dysfunction and extends healthy life expectancy. npj aging. 2025. PubMed
- Gong J et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Molecular nutrition & food research. 2018. PubMed
- Millán J et al. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2016. PubMed
- Singh DK et al. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. The Journal of pharmacology and experimental therapeutics. 2006. PubMed
- Castaño G et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clinical drug investigation. 2003. PubMed
- Peng D et al. Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults. The American journal of nursing. 2017. PubMed
- Gerards MC et al. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis. Atherosclerosis. 2015. PubMed
- Xiong Z et al. An overview of the bioactivity of monacolin K / lovastatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019. PubMed
- Cicero AFG et al. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients. 2023. PubMed
- Pirro M et al. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacological research. 2016. PubMed
- Marazzi G et al. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. The American journal of cardiology. 2015. PubMed
- Garoufi A et al. Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia. Biomolecules. 2024. PubMed
- Protic O et al. Nutraceutical Combinations in Hypercholesterolemia: Evidence from Randomized, Placebo-Controlled Clinical Trials. Nutrients. 2021. PubMed
- Coppinger C et al. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease. Current reviews in clinical and experimental pharmacology. 2024. PubMed
- Pirillo A et al. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis. 2015. PubMed
- Hamoud S et al. Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levels of high-density lipoprotein cholesterol. The American journal of the medical sciences. 2013. PubMed